Form 4 Tracker
PUMA BIOTECHNOLOGY, INC.
PBYI

15 insider filings · Latest: Sep 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 21, 2025May 21 7:00 PMLudwig Jeffrey Jerome
Proposed Sale
55,882$3.42$191.3K—

View →

Jan 2, 2025Jan 3 1:37 AMNOUGUES MAXIMO F
Proposed Sale
10,227$3.05$31.2K—

View →

Jan 2, 2025Jan 3 1:34 AMLudwig Jeffrey Jerome
Proposed Sale
9,437$3.05$28.8K—

View →

Jan 2, 2025Jan 3 1:33 AMHUNT DOUGLAS M
Proposed Sale
8,633$3.05$26.3K—

View →

Jan 2, 2025Jan 3 1:30 AMAUERBACH ALAN H
Proposed Sale
33,841$3.05$103.2K—

View →

← Previous

Page 3 of 3

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 14, 2026Sep 17 1:06 AMAlessandra CesanoDirector
Option Exercise
50,000$2.9350,000(D)

View →

Feb 18, 2026Feb 21 1:29 AMAlan H AuerbachDirector, President and CEO, 10% Owner
Grant/Award
227,474$6.68227,474(D)

View →

Feb 18, 2026Feb 21 1:28 AMDouglas M HuntThe Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer.
Grant/Award
70,321$6.6870,321(D)

View →

Feb 18, 2026Feb 21 1:28 AMMaximo F NouguesChief Financial Officer
Grant/Award
66,541$6.6866,541(D)

View →